Health vs. disease: A commentary on 'The rationale of value-laden medicine' (Kottow 2002; Journal of Evaluation in Clinical Practice 8, 77-84)

Journal of Evaluation in Clinical Practice

Volumn 9, Issue 1, 2003, Pages 89-91

  Charlton, Bruce G ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYTOTOXIC AGENT; NEUROLEPTIC AGENT; STEROID;

CLINICAL MEDICINE; CLINICAL PRACTICE; DISEASE CONTROL; DRUG SCREENING; FINANCIAL MANAGEMENT; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; NOTE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIDE EFFECT;

BIOETHICS; CLINICAL MEDICINE; COMMODIFICATION; DISEASE; ETHICS, CLINICAL; GREAT BRITAIN; HEALTH; HUMANS; SOCIAL VALUES;

EID: 0037322861     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2753.2003.00365.x     Document Type: Note

References (3)

1. Charlton B.G. (1999) Clinical research methods for the new millennium. Journal of Evaluation in Clinical Practice 5, 251-263.
2. Knutson B., Wolkowitz O.M., Cole S.W., Chan T., Moore E.A., Johnson R.C., Terpestra J., Turner R.A. & Reus V.I. (1998) Selective alteration of personality and social behavior by serotonergic intervention. American Journal of Psychiatry 155, 373-379.
3. Kottow M.H. (2002) The rationale of value-laden medicine. Journal of Evaluation in Clinical Practice 8, 77-84.